Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study

ClinicalTrials.gov Identifier: NCT05942508. Date of registration: 7 June 2023.